These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2102813)

  • 1. Depressed IL-1 production by chronic GVHD dermal fibroblasts.
    Mekori YA; Huleihel M; Baram D; Apte RN
    Eur Cytokine Netw; 1990; 1(2):77-83. PubMed ID: 2102813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of interleukin 1 generation in immune-activated fibroblasts.
    Huleihel M; Douvdevani A; Segal S; Apte RN
    Eur J Immunol; 1990 Apr; 20(4):731-8. PubMed ID: 2189735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model.
    Yamamoto A; Ashihara E; Nakagawa Y; Obayashi H; Ohta M; Hara H; Adachi T; Seno T; Kadoya M; Hamaguchi M; Ishino H; Kohno M; Maekawa T; Kawahito Y
    Immunol Lett; 2011 Mar; 135(1-2):144-50. PubMed ID: 21040744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production.
    Xiao ZY; Zhou WX; Zhang YX; Cheng JP; He JF; Yang RF; Yun LH
    Life Sci; 2007 Oct; 81(19-20):1403-10. PubMed ID: 17950363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
    Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
    Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
    Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 and pro-inflammatory cytokines produced by primary and transformed fibroblasts abrogate the tumorigenic potential of fibrosarcomas.
    Apte RN; Douvdevani A; Huleihel M; Fima E; Hacham M; Shimoni N; Dvorkin T; Segal S
    Folia Biol (Praha); 1992; 38(3-4):240-57. PubMed ID: 1426419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of interleukin-8 gene expression by gingival and dermal fibroblasts stimulated with interleukin-1beta or tumour necrosis factor alpha.
    Myokai F; Koyama E; Nishikawa K; Noji S; Murayama Y; Taniguchi S
    J Int Acad Periodontol; 2004 Jan; 6(1):21-8. PubMed ID: 14964491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine IL-10 fails to reduce GVHD despite inhibition of alloreactivity in vitro.
    Emmanouilides CE; Luo J; Baldwin G; Buckley D; Lau P; Lopez E; Tabibzadeh S; Yu J; Wolin M; Rigor R; Territo M; Black AC
    Bone Marrow Transplant; 1996 Aug; 18(2):369-75. PubMed ID: 8864448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines involved in graft-versus-host disease.
    Imamura M; Tanaka J; Hashino S; Kobayashi H; Hirano S; Minagawa T; Imai K; Kobayashi S; Fujii Y; Kasai M
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1348-53. PubMed ID: 7705747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease.
    Williamson E; Garside P; Bradley JA; More IA; Mowat AM
    J Immunol; 1997 Aug; 159(3):1208-15. PubMed ID: 9233615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
    Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
    Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal analysis of murine graft-vs-host disease. II. Leukokines that stimulate fibroblast proliferation and collagen synthesis in graft-vs. host disease.
    DeClerck Y; Draper V; Parkman R
    J Immunol; 1986 May; 136(10):3549-52. PubMed ID: 3486213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease.
    Via CS; Rus V; Gately MK; Finkelman FD
    J Immunol; 1994 Nov; 153(9):4040-7. PubMed ID: 7930611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.
    Rus V; Svetic A; Nguyen P; Gause WC; Via CS
    J Immunol; 1995 Sep; 155(5):2396-406. PubMed ID: 7650373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of IL-18 in cutaneous graft-versus-host disease.
    Park HJ; Kim JE; Lee JY; Cho BK; Lee WJ; Kim T; Yoon D; Cho D
    Immunol Lett; 2004 Aug; 95(1):57-61. PubMed ID: 15325798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell "disappearance" in chronic murine graft-vs-host disease (GVHD)-ultrastructural demonstration of "phantom mast cells".
    Claman HN; Choi KL; Sujansky W; Vatter AE
    J Immunol; 1986 Sep; 137(6):2009-13. PubMed ID: 3745920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
    Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease.
    Cleveland MG; Annable CR; Klimpel GR
    J Immunol; 1988 Nov; 141(10):3349-56. PubMed ID: 3141498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.